We are interested in establishing partnerships with financial investors and strategic corporate partners to commercialise our microRNA-based diagnostic tests for the animal health market
For further information on this exciting opportunity click belowRequest further information
Directly detecting RNA and microRNA biomarkers
Transformative technology blocking degradation of target miRNAs in plasma and serum
Samples can be prepared, shipped, and stored and then analysed without requiring refrigerationSchedule a discovery call
The next generation of veterinary tests
Providing faster, more convenient and more cost effective results
The detection of low levels of specific microRNAs (miRNAs) in tissues and fluids has great potential for the early detection of disease, illness or physiological changes in humans and animals. However, this diagnostic approach has two significant drawbacks: the reliance on costly PCR (polymerase chain reaction) equipment, and the need to send refrigerated samples to reference laboratories.
Through its partnership with DESTINA Genomics, Vetsina has access to ground breaking technologies that allow the development of RNA biomarker diagnostics that do not need PCR amplification for analysis, or refrigeration for transportation. So the next generation of veterinary tests will be able to provide results faster, more conveniently and more cost effectively both in laboratories and at the point of care.
The objective of Vetsina
Enhancing animal health and wellbeing through earlier detection of illness and disease
Vetsina aims bring a new generation of veterinary diagnostics to market based on RNA technology. These tests will enable faster, more sensitive and earlier detection of illness and disease, and so enhance animal health and wellbeing.